Key terms
About IBIO
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It focuses on the development of precision antibodies. The company was founded on April 17, 2008 and is headquartered in Bryan, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest IBIO news
Apr 16
4:12pm ET
iBio files to sell 10.57M shares of common stock for holders
Apr 01
4:53pm ET
iBio Inc. Raises $15M in Private Placement and Issues Warrants
Mar 27
7:08am ET
iBio enters collaboration agreement with AstralBio
Feb 29
10:57am ET
Biotech Alert: Searches spiking for these stocks today
Feb 29
10:57am ET
Biotech Alert: Searches spiking for these stocks today
Feb 28
11:59am ET
Biotech Alert: Searches spiking for these stocks today
Feb 28
11:59am ET
Biotech Alert: Searches spiking for these stocks today
Feb 26
8:13am ET
Ibio Inc Advances Portfolio with Strategic Asset Sale
Feb 26
7:53am ET
iBio to sell preclinical PD-1 agonist antibody program to Otsuka
No recent press releases are available for IBIO
IBIO Financials
Key terms
Ad Feedback
IBIO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
IBIO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range